B E Bax
Overview
Explore the profile of B E Bax including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talaulikar V, Bax B, Page N, Manyonda I
Placenta
. 2012 Mar;
33(6):473-9.
PMID: 22410190
Background: Discrepancies in the results from studies of early events in human trophoblast invasion of decidua have been acknowledged and are attributed largely to deficiencies in the accuracy of sampling...
2.
Moran N, Bain M, Muqit M, Bax B
Neurology
. 2008 Aug;
71(9):686-8.
PMID: 18725595
No abstract available.
3.
Bax B, Bain M, Fairbanks L, Simmonds H, Webster A, Chalmers R
Adv Exp Med Biol
. 2002 Jan;
486:47-50.
PMID: 11783525
No abstract available.
4.
Bax B, Bain M, Fairbanks L, Webster A, Chalmers R
Br J Haematol
. 2000 Jul;
109(3):549-54.
PMID: 10886203
Polyethylene glycol-conjugated adenosine deaminase (pegademase) is used for enzyme replacement therapy for patients with severe combined immunodeficiency caused by adenosine deaminase deficiency. The entrapment of pegademase within human energy-replete carrier...
5.
Bax B, Wozney J, Ashhurst D
Calcif Tissue Int
. 1999 Jun;
65(1):83-9.
PMID: 10369739
The effects of human recombinant bone morphogenetic protein-2 (rhBMP-2) on rabbit fractures healing under both stable and unstable mechanical conditions were investigated. rhBMP-2 was administered (1) on bioerodible particles, (2)...
6.
Bax B, Bain M, Talbot P, PARKER-WILLIAMS E, Chalmers R
Clin Sci (Lond)
. 1999 Jan;
96(2):171-8.
PMID: 9918897
Erythrocytes offer the exciting opportunity of being used as carriers of therapeutic agents. Encapsulation within erythrocytes will give the therapeutic agent a clearance equivalent to the normal life of the...
7.
Bax B, Bloxam D
Biochim Biophys Acta
. 1997 Apr;
1319(2-3):283-92.
PMID: 9131049
Energy metabolism and glycolysis of normal human term placental trophoblast in two-sided culture was investigated during differentiation from cytotrophoblast to syncytiotrophoblast, because glycogen metabolism is abnormal in several trophoblast related...
8.
Bloxam D, Bax B, Bax C
Placenta
. 1997 Mar;
18(2-3):99-108.
PMID: 9089769
The conditions necessary for producing syncytical syncytiotrophoblast are examined. Tissue disaggregation conditions, culture media composition, different extracellular matrices and the influence of placental gestational age are all assessed. The importance...
9.
Bloxam D, Bax C, Bax B
Placenta
. 1997 Mar;
18(2-3):93-8.
PMID: 9089768
Criteria for a successful model for the study of trans-syncytiotrophoblast transfer include isolating substantially pure trophoblast cells from placental villous tissue, and obtaining from them phenotypical villous syncytial syncytiotrophoblast during...
10.
Bax B, Fairbanks L, Bain M, Simmonds H, Chalmers R
Biochem Soc Trans
. 1996 Aug;
24(3):442S.
PMID: 8878986
No abstract available.